InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Burke Steven Keith, Vice-Président Senior et Médecin-Chef. Officer active across 1 company, notably Akebia Therapeutics, Inc.. In total, 16 reports have been recorded. Split: 0 buy · 11 sells. Total volume traded: €180k. History available since 31 August 2021. The latest transaction was filed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Burke Steven Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
21,582 shares@ US$1.3914.1% of flowCommon StockSEC:0001619834-26-000002:0
204,000 shares0Common StockSEC:0001619834-26-000001:0
7,144 shares@ US$1.838.0% of flowCommon StockSEC:0001562180-25-001997:0
194,900 shares0Common StockSEC:0001562180-25-000916:0
27,000 shares@ US$1.1518.3% of flowCommon StockSEC:0001562180-24-003948:0
7,169 shares@ US$1.586.7% of flowCommon StockSEC:0001562180-24-002020:0
8,367 shares@ US$1.527.5% of flowCommon StockSEC:0001562180-24-001993:0
202,200 shares0Common StockSEC:0001562180-24-000970:0
63,567 shares@ US$1.06839.8% of flowCommon StockSEC:0001562180-23-004254:0
6,613 shares@ US$0.87753.5% of flowCommon StockSEC:0001562180-23-002199:0
7,539 shares@ US$0.81323.7% of flowCommon StockSEC:0001562180-23-002040:0
196,200 shares0Common StockSEC:0001562180-23-000830:0
1,147 shares@ US$0.36250.3% of flowCommon StockSEC:0001562180-22-006402:0
200,000 shares0Common StockSEC:0001562180-22-004031:0
7,400 shares@ US$2.15487.9% of flowCommon StockSEC:0001562180-22-002165:0
1,042 shares@ US$2.831.4% of flowCommon StockSEC:0001562180-21-005744:0
16 of 16 declarations
About Burke Steven Keith
Burke Steven Keith is Senior Vice President and Chief Medical Officer. He has filed 16 filings in total, and in the 16 recent filings available, all transactions are sales in Akebia Therapeutics, Inc., for a combined amount of EUR 179742, with a period from 2021-09-02 to 2026-02-04.
